Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysis.
Miyashita K, Karayama M, Inoue Y, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Kono M, Matsui T, Niwa M, Koda K, Toyoshima M, Matsushima S, Matsuura S, Asada K, Fujii M, Kusagaya H, Matsuda H, Inui N, Suda T.
Miyashita K, et al. Among authors: matsushima s.
BMC Pulm Med. 2021 Oct 2;21(1):309. doi: 10.1186/s12890-021-01681-6.
BMC Pulm Med. 2021.
PMID: 34600514
Free PMC article.